» Articles » PMID: 30717396

Alterations of the Gut Microbiome in Chronic Hepatitis B Virus Infection Associated with Alanine Aminotransferase Level

Overview
Journal J Clin Med
Specialty General Medicine
Date 2019 Feb 6
PMID 30717396
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

The changes in the gut microbiota of healthy hepatitis B virus (HBV) carriers, including asymptomatic and non-cirrhotic subjects, have been rarely scrutinized. From 1463 faecal samples in health examinees, in total 112 subjects, including 36 hepatitis B surface antigen (HBsAg)-positive and 76 control subjects, were included. Twenty-eight of 36 HBsAg-positive individuals (78%) showed normal alanine aminotransferase (ALT) levels (normal ALT group), whereas eight subjects exhibited elevated ALT levels (22%, high ALT group). By using 16S rRNA gene sequencing, the distance between normal and high ALT groups among HBsAg-positive subjects showed a significant separation after the pairwise comparison of weighted UniFrac distance (permutational analysis of variance -value = 0.039), when compared with the distances to the control group. In comparison with the control group, the normal ALT group had as a significant taxon that showed a positive association (Coefficient () = 0.028, = 0.039). ( = 0.54, = 0.014) and ( = 1.41, = 0.030) showed positive correlations, and ( = -1.31, = 4.15 × 10) exhibited a negative correlation with high ALT level. Gut microbial composition was different according to HBV-induced serum ALT levels, indicative of a potential link between gut and liver metabolism.

Citing Articles

Gut microbiota shifts in hepatitis B-related portal hypertension after transjugular intrahepatic portosystemic shunt: Mechanistic and clinical implications.

Jiang Q, Zeng D World J Gastroenterol. 2025; 31(3):100752.

PMID: 39839897 PMC: 11684156. DOI: 10.3748/wjg.v31.i3.100752.


Etiology-Dependent Microbiome Differences in Hepatocellular Carcinoma Development.

Todorovic N, Martinelli S, Nannini G, Weiskirchen R, Amedei A Int J Mol Sci. 2025; 25(24.

PMID: 39769276 PMC: 11677376. DOI: 10.3390/ijms252413510.


Gut Microbiota as Mediator and Moderator Between Hepatitis B Virus and Hepatocellular Carcinoma: A Prospective Study.

Hu B, Yang Y, Yao J, Lin G, He Q, Bo Z Cancer Med. 2024; 13(24):e70454.

PMID: 39702929 PMC: 11659115. DOI: 10.1002/cam4.70454.


Role of tenofovir dipivoxil in gut microbiota recovery from HBV-infection induced dysbiosis.

Long J, Saw M, Zhang P, Wang L, Li L, Ren H BMC Microbiol. 2024; 24(1):359.

PMID: 39304810 PMC: 11414042. DOI: 10.1186/s12866-024-03457-4.


Alterations in the gut microbiome after transjugular intrahepatic portosystemic shunt in patients with hepatitis B virus-related portal hypertension.

Zhao H, Zhang J, Liu F, Yue Z, Wang L, Zhang Y World J Gastroenterol. 2024; 30(31):3668-3679.

PMID: 39193001 PMC: 11346157. DOI: 10.3748/wjg.v30.i31.3668.


References
1.
Duncan S, Louis P, Flint H . Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl Environ Microbiol. 2004; 70(10):5810-7. PMC: 522113. DOI: 10.1128/AEM.70.10.5810-5817.2004. View

2.
Lozupone C, Knight R . UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol. 2005; 71(12):8228-35. PMC: 1317376. DOI: 10.1128/AEM.71.12.8228-8235.2005. View

3.
Hamer H, Jonkers D, Venema K, Vanhoutvin S, Troost F, Brummer R . Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther. 2007; 27(2):104-19. DOI: 10.1111/j.1365-2036.2007.03562.x. View

4.
Beasley R . Rocks along the road to the control of HBV and HCC. Ann Epidemiol. 2009; 19(4):231-4. DOI: 10.1016/j.annepidem.2009.01.017. View

5.
Chae H, Kim J, Kim J, Yim H . Current status of liver diseases in Korea: hepatitis B. Korean J Hepatol. 2009; 15 Suppl 6:S13-24. DOI: 10.3350/kjhep.2009.15.S6.S13. View